1Y Annualised Return
▼-18.86%
3Y Annualised Return
▼-25.35%
Over the past
Open
892.60
Prev. Close
900.80
Total Traded Value
3.57 Cr
Market Cap (in crs)
2,145.87
Face Value
10
Turnover (in lacs)
356.87
*All values are in ₹ Cr.
*All values are in ₹ Cr.
*All values are in ₹ Cr.
*All values are in ₹ Cr.
Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 |
---|---|---|---|---|
107.86 Cr | 85.9 Cr | 83.49 Cr | 105.46 Cr | 98.27 Cr |
Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
---|---|---|---|---|---|
385.03 Cr | 401.01 Cr | 429.36 Cr | 442.54 Cr | 306.29 Cr | 264.62 Cr |
Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 |
---|---|---|---|---|
1.03 Cr | 0.14 Cr | -0.66 Cr | 5.21 Cr | 9.61 Cr |
Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
---|---|---|---|---|---|
5.71 Cr | 30.35 Cr | 45.49 Cr | 95.87 Cr | 52.26 Cr | 37.79 Cr |
Tatva Chintan Pharma Chem Ltd reported a 19.6% quarter-on-quarter (QoQ) increase in its consolidated revenues for the quarter-ended Mar (Q4FY25). On a year-on-year (YoY) basis, it witnessed a decline of 18.0%.
Its expenses for the quarter were up by 3.4% QoQ and down 21.8% YoY.
The net profit increased 6764.3% QoQ and decreased 43.3% YoY.
The earnings per share (EPS) of Tatva Chintan Pharma Chem Ltd stood at 4.1 during Q4FY25.
Data Source: BSE, Company announcements
The securities quoted are exemplary and are not recommendatory. Past performance is not indicative of future results.
Period | Combined Delivery Volume | NSE+BSE Traded Volume |
---|---|---|
Day Rs | 12359 Rs | 42483 Rs |
Week Rs | 16133 Rs | 40791 Rs |
Month Rs | 26721 Rs | 67936 Rs |
B
N
V
J
T
Y
Index Name | Market Price | Market Cap | 52W Low | 52W High | Prev. Close | 1W Return | 1M Return | 6M Return | 1Y Return | 3Y Return | Dividend Yield | PE Ratio | Industry PE | PB Ratio |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
110.50 | 2,750.88 | 90 | 177 | 109.45 | -4.12% | -3.53% | -21.72% | -12.14% | 67.23% | 3.64% | 15.19 | 29.38 | 2.73 | |
183.56 | 3,060.40 | 158.1 | 336 | 183.07 | -8.00% | 2.38% | -27.07% | -40.68% | -21.53% | 1.09% | 28.49 | 49.83 | 1.75 | |
420.00 | 2,094.94 | 397.1 | 569.15 | 420.20 | -0.66% | -5.79% | -22.82% | -7.97% | 20.74% | 0.96% | 48.03 | 49.83 | 6.92 | |
1,604.94 | 1010.6 | 1635 | 1,338.95 | -0.24% | -1.84% | 0.97% | -6.64% | 83.54% | 0.67% | 21.72 | 49.83 | 7.55 | ||
930.75 | 1,589.87 | 799.1 | 2179.2 | 918.00 | -0.31% | -10.25% | -35.39% | -44.19% | 589.41% | 0.43% | 36.83 | 70.48 | 9.24 | |
2,335.58 | 1614 | 2343.85 | 1,910.00 | -1.94% | 12.56% | -5.68% | 1.16% | 0.00% | 0.03% | 385.23 | 49.83 | 5.51 |
As of 20 Jun, 2025, Tatva Chintan Pharma Chem share price is ₹917.4. The stock opened at ₹892.6 and had closed at ₹900.8 the previous day. During today’s trading session, Tatva Chintan Pharma Chem share price moved between ₹886.00 and ₹921.95, with an average price for the day of ₹903.98. Over the last 52 weeks, the stock has recorded a low of ₹621.00 and a high of ₹1,222.00. In terms of performance, Tatva Chintan Pharma Chem share price has increased by 8.8% over the past six months and has declined by 18.86% over the last year.
Tatva Chintan Pharma Chem share price is ₹915.1 in NSE and ₹921 in BSE as on 20/6/2025.
Tatva Chintan Pharma Chem share price in the past 1-year return was -17.37. The Tatva Chintan Pharma Chem share hit a 1-year low of Rs. 621 and a 1-year high of Rs. 1222.
The market cap of Tatva Chintan Pharma Chem is Rs. 2145.87 Cr. as of 20/6/2025.
The PE ratios of Tatva Chintan Pharma Chem is 0 as of 20/6/2025.
The PB ratios of Tatva Chintan Pharma Chem is 2.97 as of 20/6/2025
The Mutual Fund Shareholding in Tatva Chintan Pharma Chem was 5.34% at the end of 20/6/2025.
You can easily buy Tatva Chintan Pharma Chem shares in Kotak Securities by opening a demat account and getting the KYC documents verified online.
Please be aware that Tatva Chintan Pharma Chem stock prices are subject to continuous fluctuations due to various factors.